Sep 2026· Current pharmaceutical design· 0 citations
Medicine
TL;DR
A promising approach to cancer therapy is presented by integrating polyphenol-based nanoformulations into hybrid nanoformulations, addressing key limitations of conventional polyphenol delivery and thereby enhancing their anticancer potential through multiple molecular pathways.
Abstract
INTRODUCTION
Cancer remains the leading cause of death globally. Conventional cancer treatments are capable of effectively targeting tumor cells; however, they might trigger immunosuppression, multidrug resistance, and harm healthy cells. Polyphenols are nutraceuticals-based naturally occurring phytochemicals with promising nutraceutical, antioxidant, antineoplastic, anti-inflammatory, and free-radical scavenging properties. This review highlights strategies for encapsulating them within hybrid nanostructures to overcome their limitations of poor aqueous solubility, low bioavailability, and lack of target specificity. Moreover, it provides insights into the major molecular signaling pathways underlying the anticancer activity of polyphenols and their hybrid nanoformulations.
Methods
A comprehensive literature review was conducted from accredited databases, including Google Scholar, Scopus, PubMed, and Web of Science (1996 to present), on naturally occurring polyphenols and their encapsulation into hybrid formulations. Emphasis was placed on hybrid nanocarriers, with keywords including dendrimers, micelles, polymers, mesoporous silica, gold nanoparticles, and carbon nanotubes, prepared by combining inorganic nanoparticles with organic lipids or polymers.
Results
Polyphenols exhibit promising nutraceutical, antioxidant, antineoplastic, anti-inflammatory, and freeradical- scavenging properties, along with significant potential to modulate oxidative stress, apoptosis, metabolism, proliferation, inflammation, angiogenesis, and tumor signaling pathways, including MAPK, PI3K/Akt/ mTOR, Wnt/β-catenin, and STAT3. Encapsulation of polyphenols into Hybrid Nanoformulations (HNs) yields a synergistic system that significantly improves stability, bioavailability, targeted delivery, and effectiveness in cancer treatment. HNs further demonstrated the potential to integrate the advantages of multiple delivery systems, thereby improving therapeutic outcomes and reducing systemic toxicity.
Discussion
The available studies highlight hybrid nanoformulations as a versatile platform to maximize the therapeutic potential of polyphenols in cancer treatment. Integrating the advantages of different nanocarrier systems offers new strategies for developing more effective and targeted cancer therapies.
Conclusion
This review presents a promising approach to cancer therapy by integrating polyphenols into hybrid nanoformulations, addressing key limitations of conventional polyphenol delivery and thereby enhancing their anticancer potential through multiple molecular pathways. However, despite the encouraging benefits, no polyphenol-based nanoformulation has yet been approved by the US FDA for cancer therapy due to limited clinical evidence, challenges associated with large-scale manufacturing, regulatory concerns, and long-term safety assessment. Further preclinical validation and clinical studies are required to facilitate the successful application of polyphenolic hybrid nanoformulations in cancer management.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies worldwide due to late-stage diagnosis, aggressive progression, and limited therapeutic responsiveness. Although herbal-derived bioactive compounds have demonstrated promising anticancer potential, their clinical application is often res...
Ghazala Muteeb, Youssef Basem, Amira A. Kotb et al.· Nanomaterials· 0 citations
The current role of green-synthesized NPs in renal cell carcinoma management and their applications in targeted drug delivery and cancer-specific targeting mechanisms are focused on and the environmentally friendly green synthesis approaches utilizing biological resources such as plant extracts and microorganisms are h...
Mariam R. Khalifa, Doaa S. R. Khafaga, Marwa T. Abo Gabal et al.· International Journal of Mol...· 0 citations
This review evaluates diverse nanoparticle-based delivery systems and their targeting mechanisms in natural product-based breast cancer therapy and concludes that natural products possess potent anti-breast cancer effects, and the application of nanodelivery technology effectively overcomes their inherent limitations o...
Kai-Yan Su, Yan Li, Dong-Mei Zhang et al.· Pharmaceutics· 0 citations
Background and purpose: Colorectal cancer (CRC) continues to be a major contributor to cancer-related mortality despite advances in diagnosis and management, highlighting the need for targeted, cost-effective therapies. Phytochemicals like curcumin (Cur) and silibinin (Sil) show promising anticancer effects, supported...
Fatemeh Toroghi, Davood Jafari, R. Najafi et al.· Advanced Pharmaceutical Bull...· 0 citations
Phytochemicals have gained remarkable attention because of their broad-spectrum therapeutic activities, including antioxidant, anti-inflammatory, antimicrobial, neuroprotective, and anticancer effects. Despite their pharmacological potential, the clinical translation of many phytochemicals remains limited due to poor a...
G. Pramoda, Rahul Shukla· Chemical Communications· 0 citations
Polyphenols are among the most versatile secondary metabolites of plants, with significant therapeutic potential, including anti-inflammatory, cardioprotective, and antioxidant properties. However, limited bioavailability impedes their clinical application. These improvements have led to the use of synthetic stabilizer...
Arya Ojha, Sweta Acharya, Adarsh Sharma et al.· Frontiers in Food Science an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.